A NEW report from the Australian
Institute of Health and Welfare
predicts a significant rise in new
cases of end-stage kidney disease
(ESKD) treated with dialysis or
kidney transplantation over the
next decade.
The main contributing factors to
the increase are Australia’s ageing
population along with increasing
rates of diabetes.
The Pharmacist Coalition for
Health Reform has responded to
the figures by calling for a greater
role for pharmacists in the
management of chronic disease.
PCHR spokesperson, PSA ceo
Lisel Wett, said pharmacists were
“currently being under utilised and
can play a crucial role working
alongside other health care
professionals to help patients
managing chronic illnesses such as
diabetes and kidney disease”.The above article was sent to subscribers in Pharmacy Daily's issue from 16 Sep 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Sep 11
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.